Mercer Global Advisors »

Vir Biotechnology shares owned by Mercer Global Advisors

Quarter-by-quarter ownership of Vir Biotechnology (VIR) shares owned by Mercer Global Advisors from 13F filings

Historical chart of Mercer Global Advisors investment in Vir Biotechnology

Tip: Access up to 7 years of quarterly data

All positions including Vir Biotechnology held by Mercer Global Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vir Biotechnology by Mercer Global Advisors

Quarter filed Position value Share count Share price at filing
2023-06-30 $1.2M 48k 24.54
2023-03-31 $924k 40k 23.26
2022-12-31 $908k 36k 25.32
2022-09-30 $664k 35k 19.27

More positions owned by Mercer Global Advisors

Ishares Tr Core Us Aggbd Et (AGG)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Bd Index Fds Short Trm Bond (BSV)
Dimensional Etf Trust Us Core Equity 2 (DFAC)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr Msci Usa Mmentm (MTUM)
Dimensional Etf Trust Us Mktwide Value (DFUV)
Dimensional Etf Trust Us High Profitab (DUHP)
Vanguard Charlotte Fds Total Int Bd Etf (BNDX)
Apple (AAPL)
Dimensional Etf Trust Intl Core Equity (DFIC)
Ishares Tr Msci Intl Moment (IMTM)
NVIDIA Corporation (NVDA)
Dimensional Etf Trust Internatnal Val (DFIV)
Microsoft Corporation (MSFT)

View all positions for Mercer Global Advisors

Top funds holding Vir Biotechnology

Sb Investment Advisers
BlackRock
Arch Venture Corp
Vanguard Group
State Street Corporation
FMR
Dimensional Fund Advisors
OrbiMed Advisors
Geode Capital Management
Goldman Sachs Group
Millennium Management
Standard Life Aberdeen
Renaissance Technologies
Charles Schwab Investment Management
Hudson Bay Capital Management

View all funds holding Vir Biotechnology